Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
Senate committee advances bill to bar step-therapy requirements for metastatic cancer patients
Summary
The Senate Insurance & Commerce committee voted to pass Senate Bill 446, which would prohibit health plans from requiring "step therapy" (fail-first) for metastatic cancer patients so physicians can prescribe what they judge best without mandated prior trials of lower-cost alternatives.
A Senate Insurance & Commerce committee on an Arkansas legislative hearing advanced legislation intended to speed access to prescribed cancer drugs for patients with metastatic disease.
Senate Bill 446, introduced by Senator Greg Lettering, would ban step therapy — sometimes called "fail-first" requirements — for people the bill defines as having metastatic cancer. Lettering told the committee the bill’s core provision appears on page 2, line 12 and that the goal is "to make…
Already have an account? Log in
Subscribe to keep reading
Unlock the rest of this article — and every article on Citizen Portal.
- Unlimited articles
- AI-powered breakdowns of topics, speakers, decisions, and budgets
- Instant alerts when your location has a new meeting
- Follow topics and more locations
- 1,000 AI Insights / month, plus AI Chat
